Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma

BACKGROUND/AIMS: Antiviral therapy is a key component in the management of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients. However, whether the potent drug entecavir is more effective than a less potent drug, such as lamivudine, in HBV-related HCC is not clear. METHODS: A re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung Hee, Sinn, Dong Hyun, Kim, Kyunga, Kim, Hyeseung, Gwak, Geum-Youn, Paik, Yong-Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Paik, Seung Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087934/
https://www.ncbi.nlm.nih.gov/pubmed/27282264
http://dx.doi.org/10.5009/gnl15527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087934/
https://www.ncbi.nlm.nih.gov/pubmed/27282264
http://dx.doi.org/10.5009/gnl15527

Ejemplares similares